Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
02 Oct 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/jj-invest-more-than-2-billion-new-manufacturing-facility-2024-10-01/
01 Oct 2024
// FIERCE HEALTH
https://www.fiercehealthcare.com/providers/hrsa-hospitals-say-jjs-plan-340b-discounts-rebate-not-supported-statute
01 Oct 2024
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/pharma/jj-legend-solidify-carvyktis-earlier-multiple-myeloma-lead-strong-survival-showing
30 Sep 2024
// BUSINESSWIRE
27 Sep 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/after-sanofis-first-line-myeloma-nod-jj-strikes-back-new-tranche-darzalex-data
27 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/27/2954641/0/en/DARZALEX-daratumumab-subcutaneous-SC-formulation-based-quadruplet-regimen-significantly-improves-minimal-residual-disease-negativity-for-newly-diagnosed-multiple-myeloma-patients-f.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Nicotine bulk with DMF offered by Johnson & Johnson
Find a price of Naloxone Hydrochloride bulk offered by Johnson & Johnson
LOOKING FOR A SUPPLIER?